Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis

被引:6
作者
Li, Chengzhuo [1 ,2 ]
Han, Didi [1 ,2 ]
Huang, Qiao [3 ]
Xu, Fengshuo [1 ,2 ]
Zheng, Shuai [1 ,4 ]
Li, Xiang [5 ]
Zhao, Fanfan [1 ,2 ]
Feng, Xiaojie [1 ,2 ]
Lyu, Jun [1 ,2 ]
机构
[1] Jinan Univ, Dept Clin Res, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Publ Hlth, Xian, Shaanxi, Peoples R China
[3] Wuhan Univ Zhongnan Hosp, Dept Chemotherapy & Radiat Therapy, Wuhan, Hubei, Peoples R China
[4] Shaanxi Univ Chinese Med, Xianyang, Peoples R China
[5] Xi An Jiao Tong Univ, Xian, Peoples R China
来源
BMJ OPEN | 2021年 / 11卷 / 07期
关键词
epidemiology; urology; urological tumours; CELL-CARCINOMA; RADICAL NEPHROURETERECTOMY; EUROPEAN ASSOCIATION; UROLOGY GUIDELINES; TUMOR SIZE; SURVIVAL; EPIDEMIOLOGY; CHEMOTHERAPY; RECURRENCE; MORTALITY;
D O I
10.1136/bmjopen-2020-048243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to use a competing-risks model to establish a nomogram to accurately analyse the prognostic factors for upper tract urothelial carcinoma (UTUC) cancer-specific death (CSD). Design Retrospective observational cohort study. Setting The programme has yielded a database of all patients with cancer in 18 defined geographical regions of the USA. Participants We selected patients with UTUC from the latest edition of the Surveillance, Epidemiology, and End Results database from 1975 to 2016. After excluding patients with unknown histological grade, tumour size and lymph node status, 2576 patients were finally selected. Primary and secondary outcome measures We used the Fine-Gray proportional subdistribution hazards model for multivariate analysis and compared the results with cause-specific hazards model. We finally constructed a nomogram for 3-year, 5-year and 8-year CSD rates and tested these rates in a validation cohort. Results The proportional subdistribution hazards model showed that sex, tumour size, distant metastasis, surgery status, number of lymph nodes positive (LNP) and lymph nodes ratio (LNR) were independent prognostic factors for CSD. All significant factors associated with CSD were included in the nomogram. The 3-year, 5-year and 8-year concordance indexes were 0.719, 0.702 and 0.692 in the training cohort and 0.701, 0.675 and 0.668 in the validation cohort, respectively. Conclusions The competing-risks model showed that sex, tumour size, distant metastasis, surgery status, LNP and LNR were associated with CSD. The nomogram predicts the probability of CSD in patients with UTUC at 3, 5 and 8 years, which may help clinicians in predicting survival probabilities in individual patients.
引用
收藏
页数:11
相关论文
共 39 条
  • [1] Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort
    Abdollah, Firas
    Sun, Maxine
    Schmitges, Jan
    Tian, Zhe
    Jeldres, Claudio
    Briganti, Alberto
    Shariat, Shahrohk F.
    Perrotte, Paul
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2011, 60 (05) : 920 - 930
  • [2] About the SEER Program. National Cancer Institute
  • [3] n.d Fall, 2014, SURV EP END RES PROG
  • [4] Practical recommendations for reporting Fine-Gray model analyses for competing risk data
    Austin, Peter C.
    Fine, Jason P.
    [J]. STATISTICS IN MEDICINE, 2017, 36 (27) : 4391 - 4400
  • [5] Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma
    Bolenz, Christian
    Fernandez, Mario I.
    Trojan, Lutz
    Herrmann, Edwin
    Becker, Andreas
    Weiss, Christel
    Alken, Peter
    Stroebel, Philipp
    Michel, Maurice Stephan
    [J]. UROLOGY, 2008, 72 (02) : 364 - 369
  • [6] Cardiovascular Disease Mortality Among Breast Cancer Survivors
    Bradshaw, Patrick T.
    Stevens, June
    Khankari, Nikhil
    Teitelbaum, Susan L.
    Neugut, Alfred I.
    Gammon, Marilie D.
    [J]. EPIDEMIOLOGY, 2016, 27 (01) : 6 - 13
  • [7] Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection
    Espiritu, Patrick N.
    Sverrisson, Einar F.
    Sexton, Wade J.
    Pow-Sang, Julio M.
    Poch, Michael A.
    Dhillon, Jasreman
    Spiess, Philippe E.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 619 - 624
  • [8] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [9] Therapeutic strategies for upper tract urothelial carcinoma
    Freifeld, Yuval
    Krabbe, Laura-Maria
    Clinton, Timothy N.
    Woldu, Solomon L.
    Margulis, Vitaly
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (08) : 765 - 774
  • [10] Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
    Green, David A.
    Rink, Michael
    Xylinas, Evanguelos
    Matin, Surena F.
    Stenzl, Arnulf
    Roupret, Morgan
    Karakiewicz, Pierre I.
    Scherr, Douglas S.
    Shariat, Shahrokh F.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04) : 1214 - 1221